DETERMINATION OF TICLOPIDINE IN HUMAN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY AND ULTRAVIOLET ABSORBENCY DETECTION

被引:9
作者
DALBO, L
VERGA, F
MARZO, A
AMBROSOLI, L
POLI, A
机构
[1] IPAS SA, DEPT CLIN PHARMACOL, CH-6855 STABIO, SWITZERLAND
[2] POLI IND CHIM SPA, DEPT RES & DEV, I-20089 QUINTO DEI STAMPI, ITALY
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 1995年 / 665卷 / 02期
关键词
D O I
10.1016/0378-4347(94)00539-H
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A simple HPLC method has been developed for the determination of ticlopidine in human plasma. Plasma samples were buffered at pH 9 and extracted with n-heptane-isoamyl alcohol (98.5:1.5, v/v). Imipramine was used as internal standard. Chromatography was performed isocratically with acetonitrile-methanol-0.05 M KH2PO4 (20:25:55, v/v) at pH 3.0 containing 3% triethylamine at a flow-rate of 1 ml/min. A reversed-phase column Supelcosil LC-8-DB, 15 cm x 4.6 mm I.D., 5 mu m particle size, was used. The effluent was monitored by UV absorbance detection at 235 nm. The method showed good accuracy, precision and linearity in the concentration range 5-1200 ng/ml. The limit of quantitation was 5 ng/ml, with a precision (C.V.) of 8.91%, which is the same as that achieved by other authors with a previously published GC-MS method. The procedure described in this paper is simple and allows the routine assessment of ticlopidine plasma concentration in pharmacokinetic studies following therapeutic doses in human subjects.
引用
收藏
页码:404 / 409
页数:6
相关论文
共 9 条
[1]   QUANTITATIVE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC, GAS-CHROMATOGRAPHIC, AND GAS-CHROMATOGRAPHIC MASS-SPECTROMETRIC ANALYSIS OF TICLOPIDINE IN BABOON PLASMA AFTER SOLID-PHASE EXTRACTION [J].
ARNOUX, P ;
SALES, Y ;
MANDRAY, M ;
LECHAT, P ;
BERGER, Y ;
CANO, JP .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1991, 80 (11) :1092-1095
[2]  
BRUNO JJ, 1983, THROMB RES, P59
[3]   THE CANADIAN AMERICAN TICLOPIDINE STUDY (CATS) IN THROMBOEMBOLIC STROKE [J].
GENT, M ;
EASTON, JD ;
HACHINSKI, VC ;
PANAK, E ;
SICURELLA, J ;
BLAKELY, JA ;
ELLIS, DJ ;
HARBISON, JW ;
ROBERTS, RS ;
TURPIE, AGG .
LANCET, 1989, 1 (8649) :1215-1220
[4]   PHARMACOKINETICS OF TICLOPIDINE DURING CHRONIC ORAL-ADMINISTRATION TO HEALTHY-VOLUNTEERS AND ITS EFFECTS ON ANTIPYRINE PHARMACOKINETICS [J].
KNUDSEN, JB ;
BASTAIN, W ;
SEFTON, CM ;
ALLEN, JG ;
DICKINSON, JP .
XENOBIOTICA, 1992, 22 (05) :579-589
[5]  
Picard-Fraire C, 1984, Agents Actions Suppl, V15, P68
[6]   TICLOPIDINE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC EFFICACY IN PLATELET-DEPENDENT DISEASE STATES [J].
SALTIEL, E ;
WARD, A .
DRUGS, 1987, 34 (02) :222-262
[7]   EFFECT OF FOOD AND ANTACID ON ABSORPTION OF ORALLY-ADMINISTERED TICLOPIDINE HYDROCHLORIDE [J].
SHAH, J ;
FRATIS, A ;
ELLIS, D ;
MURAKAMI, S ;
TEITELBAUM, P .
JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 30 (08) :733-736
[8]  
SHAH J, 1991, BRIT J CLIN PHARMACO, V32, P761
[9]  
TUONG A, 1981, J DRUG METAB PHARM, V6, P91